Overactive bladder: drug therapy reduces resource use

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.363, 2002-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The pharmacokinetic evaluation of mirabegron as an overactive bladder therapy option

By Kashyap Mahendra Tyagi Pradeep

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 5, 2013-05 ,pp. : 617-627

Informa Healthcare

Access to resources Recommend Favorite

Fesoterodine: a guide to its use in overactive bladder syndrome

Drugs & Therapy Perspectives, Vol. 26, Iss. 1, 2010-01 ,pp. : 5-7

Adis International

Access to resources Recommend Favorite

Tolterodine: A Review of its Use in the Treatment of Overactive Bladder

By Clemett D. Jarvis B.

Drugs & Aging, Vol. 18, Iss. 4, 2001-04 ,pp. : 277-304

Adis International

Access to resources Recommend Favorite

Drug Treatment of Overactive Bladder: Efficacy, Cost and Quality-of-Life Considerations

By Hashim Hashim Paul Abrams

Drugs, Vol. 64, Iss. 15, 2004-01 ,pp. : 1643-1656

Adis International

Access to resources Recommend Favorite

Parecoxib reduces postop resource use

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite